tiprankstipranks
Clps Inc (CLPS)
NASDAQ:CLPS

Clps (CLPS) AI Stock Analysis

Compare
138 Followers

Top Page

CLPS

Clps

(NASDAQ:CLPS)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
$0.97
▲(3.76% Upside)
Action:UpgradedDate:01/29/26
The score is held down primarily by weak financial performance—especially negative margins and negative operating/free cash flow—while technicals provide partial support as the stock trades above major moving averages with a positive MACD. Valuation is constrained by losses (negative P/E) and no dividend yield data.
Positive Factors
Geographic diversification & overseas growth
Rapid growth outside mainland China reduces client concentration risk and makes revenue less dependent on a single market. Continued expansion in APAC and the U.S. broadens the addressable market, strengthens sales pipeline, and supports more stable multi-market revenue over the medium term.
Negative Factors
Negative profitability and weak margins
Sustained negative margins indicate the company currently cannot convert revenue into reliable profits. Without structural margin improvement via pricing, mix shift to higher-margin services, or cost efficiencies, profitability shortfalls will limit reinvestment and long-term shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Geographic diversification & overseas growth
Rapid growth outside mainland China reduces client concentration risk and makes revenue less dependent on a single market. Continued expansion in APAC and the U.S. broadens the addressable market, strengthens sales pipeline, and supports more stable multi-market revenue over the medium term.
Read all positive factors

Clps (CLPS) vs. SPDR S&P 500 ETF (SPY)

Clps Business Overview & Revenue Model

Company Description
CLPS Incorporation provides information technology, consulting, and solutions to institutions operating in banking, insurance, and financial sectors in the People's Republic of China and internationally. It offers IT consulting services in credit ...
How the Company Makes Money
Clps generates revenue through multiple streams, primarily by offering IT consulting and software development services to clients in diverse industries. The company's revenue model includes charging for project-based services, ongoing maintenance ...

Clps Financial Statement Overview

Summary
Revenue grew modestly (6.93%), but profitability is weak with negative net, EBIT, and EBITDA margins, and cash generation is a key concern given negative operating and free cash flow. Balance sheet leverage has risen but remains manageable, though negative ROE reflects recent losses.
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
BreakdownJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue164.48M142.81M150.36M152.02M126.06M
Gross Profit34.43M31.69M33.26M40.08M40.17M
EBITDA-3.20M-590.87K1.99M8.60M9.00M
Net Income-7.05M-2.33M192.53K4.46M6.82M
Balance Sheet
Total Assets118.11M110.03M95.32M101.88M82.73M
Cash, Cash Equivalents and Short-Term Investments29.07M31.22M22.21M18.40M28.90M
Total Debt33.87M26.23M11.37M14.47M7.55M
Total Liabilities60.52M46.11M29.81M34.08M25.00M
Stockholders Equity55.54M62.51M64.58M66.55M56.69M
Cash Flow
Free Cash Flow-3.80M6.81M9.19M-17.55M-3.68M
Operating Cash Flow-2.54M8.93M9.71M3.20M-2.61M
Investing Cash Flow-1.75M-12.25M-306.05K-16.29M-6.08M
Financing Cash Flow2.90M10.19M-4.32M7.47M19.80M

Clps Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.93
Price Trends
50DMA
1.04
Negative
100DMA
0.96
Negative
200DMA
0.98
Negative
Market Momentum
MACD
-0.03
Positive
RSI
38.33
Neutral
STOCH
24.47
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CLPS, the sentiment is Negative. The current price of 0.93 is below the 20-day moving average (MA) of 1.02, below the 50-day MA of 1.04, and below the 200-day MA of 0.98, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 38.33 is Neutral, neither overbought nor oversold. The STOCH value of 24.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CLPS.

Clps Risk Analysis

Clps disclosed 80 risk factors in its most recent earnings report. Clps reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Clps Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
56
Neutral
$29.39M-11.37-4.28%-20.20%-799.54%
53
Neutral
$47.09M-18.87-17.62%9.62%26.59%
51
Neutral
$28.38M70.02-11.94%15.17%-172.09%
51
Neutral
$31.08M-14.58-13.52%3.24%-115.15%
44
Neutral
$4.86M-1.86-135.84%-81.60%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CLPS
Clps
0.95
-0.26
-21.24%
WYY
Widepoint
4.77
1.24
35.13%
USIO
Usio
1.12
-0.44
-28.21%
DTST
Data Storage
3.92
0.04
1.03%
VEEA
Veea
0.54
-1.05
-65.79%
CYCU
Cycurion
1.16
-15.31
-92.96%

Clps Corporate Events

CLPS Posts Strong H1 FY2026 Growth as Overseas, AI and Web3 Initiatives Offset China Headwinds
Mar 6, 2026
On March 6, 2026, CLPS reported unaudited results for the six months ended December 31, 2025, showing revenue up 2.8% year over year to $85.1 million and net income rising 74.9% to $0.3 million, despite ongoing headwinds from a key client’s ...
CLPS Incorporation Sets February Share Buyback Plan
Feb 4, 2026
The board authorized a share repurchase program announced on February 4, 2026, allowing CLPS to buy back up to 1,000,000 common shares when the price falls below US$2.00 between February 5 and November 4, 2026, aiming to enhance market value and p...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 29, 2026